Bacterial meningitis (IDSA 2004): Difference between revisions

Content deleted Content added

Inline

Revision as of 19:32, 15 August 2019

Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, Whitley RJ. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004 Nov 1;39(9):1267-84. Epub 2004 Oct 6. doi: 10.1086/425368

Table 4: Empiric Treatment

Population	Common pathogens	Antimicrobial therapy
Age
<1 month	GBS, E.coli, Listeria, Klebsiella	amp + cefotax, or amp + AG
1-23 months	S.pneumo, N.mening, GBS, H.flu, E.coli	vanco + 3G ceph
2-50 years	N.mening, S.pneumo	vanco + 3G ceph
>50 years	S.pneumo, N.mining, Listeria, GNBs	vanco + 3G ceph + amp
Head trauma
Basilar skull fracture	S.pneumo, H.flu, GAS	vanco + 3G ceph
Penetrating trauma	Staph.aureus, CoNS, GNBs	vanco + cefep, or vanco + ceftaz, or vanco + mero
Post-neurosurgery	GNBs, Staph.aureus, CoNS	vanco + cefep, or vanco + ceftaz, or vanco + mero
CSF shunt	CoNS, Staph,aureus, GNBs, P.acnes	vanco + cefep, or vanco + ceftaz, or vanco + mero

Revision as of 19:57, 13 August 2019 view source Aidan (talk \| contribs) Bureaucrats, Interface administrators, Administrators 10,384 edits mNo edit summary ← Older edit		Revision as of 19:32, 15 August 2019 view source Aidan (talk \| contribs) Bureaucrats, Interface administrators, Administrators 10,384 edits No edit summary Newer edit →
Line 3:		Line 3:


	= Table 4: Empiric Treatment =		== Table 4: Empiric Treatment ==

	{\|		{\|